NCT03159936View on ClinicalTrials.gov

Oral Tofacitinib in Adult Subjects With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE)

EARLY_PHASE1TerminatedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

April 3, 2017

Primary Completion Date

May 13, 2020

Study Completion Date

June 10, 2020

Conditions
Discoid Lupus ErythematosusSystemic Lupus Erythematosus
Interventions
BIOLOGICAL

Tofacitinib citrate

10 mg daily by mouth

Trial Locations (1)

02111

Tufts Medical Center, Boston

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Tufts Medical Center

OTHER